On-resin synthesis of Lanreotide epimers and studies of their structure–activity relationships†

IF 3.597 Q2 Pharmacology, Toxicology and Pharmaceutics
MedChemComm Pub Date : 2024-07-01 DOI:10.1039/D4MD00338A
Arnab Chowdhury, Nitesh Mani Tripathi, Rohit Jadav, Vinod Gour, Parva Purohit and Anupam Bandyopadhyay
{"title":"On-resin synthesis of Lanreotide epimers and studies of their structure–activity relationships†","authors":"Arnab Chowdhury, Nitesh Mani Tripathi, Rohit Jadav, Vinod Gour, Parva Purohit and Anupam Bandyopadhyay","doi":"10.1039/D4MD00338A","DOIUrl":null,"url":null,"abstract":"<p >Peptide drugs often accompany epimeric impurities (isomers). Therefore, efficient chemical synthesis of epimers is critical to identify them correctly and investigate their biological activities. Here, we report the rapid synthesis and structure–activity relationship (SAR) studies of eight possible epimers of a somatostatin synthetic analog (SSA), lanreotide (LAN). SPPS and the subsequent on-resin rapid disulfide closure method offered &gt;90% conversion yield for all epimers (<strong>P1–P8</strong>). Further, we developed an analytical method to separate these epimers, which enabled the profiling of five epimeric impurities in the API, purchased for Somatuline generic formulations. In SAR studies, most LAN epimers revealed compromised antiproliferative activity, while the <strong>P7</strong> epimer retained antiproliferative activity similar to LAN API, as supported by <em>in silico</em> SAR studies in detail. Additionally, <strong>P7</strong> showed serum stability nearly identical to LAN, suggesting that drug epimers could be a potential API. Current studies will further encourage the development of novel SSA scaffolds.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 8","pages":" 2766-2772"},"PeriodicalIF":3.5970,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00338a","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Peptide drugs often accompany epimeric impurities (isomers). Therefore, efficient chemical synthesis of epimers is critical to identify them correctly and investigate their biological activities. Here, we report the rapid synthesis and structure–activity relationship (SAR) studies of eight possible epimers of a somatostatin synthetic analog (SSA), lanreotide (LAN). SPPS and the subsequent on-resin rapid disulfide closure method offered >90% conversion yield for all epimers (P1–P8). Further, we developed an analytical method to separate these epimers, which enabled the profiling of five epimeric impurities in the API, purchased for Somatuline generic formulations. In SAR studies, most LAN epimers revealed compromised antiproliferative activity, while the P7 epimer retained antiproliferative activity similar to LAN API, as supported by in silico SAR studies in detail. Additionally, P7 showed serum stability nearly identical to LAN, suggesting that drug epimers could be a potential API. Current studies will further encourage the development of novel SSA scaffolds.

Abstract Image

Abstract Image

兰瑞奥肽表聚体的树脂上合成及其结构-活性关系研究
肽类药物通常伴有表聚杂质(异构体)。因此,高效地化学合成外延物对于正确识别外延物和研究其生物活性至关重要。在此,我们报告了一种体生长激素合成类似物(SSA)兰瑞奥肽(LAN)的八种可能的外显子的快速合成和结构-活性关系(SAR)研究。SPPS和随后的树脂上快速二硫键闭合方法为所有外延物(P1-P8)提供了90%的转化率。此外,我们还开发了一种分离这些表聚物的分析方法,从而能够分析为索马图林非专利制剂采购的原料药中的五种表聚物杂质。在 SAR 研究中,大多数 LAN 表聚物的抗增殖活性都受到了影响,而 P7 表聚物则保留了与 LAN API 相似的抗增殖活性,这一点在详细的硅学 SAR 研究中得到了证实。此外,P7 的血清稳定性与 LAN 几乎相同,这表明药物表聚物可能是一种潜在的原料药。目前的研究将进一步促进新型 SSA 支架的开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
MedChemComm
MedChemComm BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
4.70
自引率
0.00%
发文量
0
审稿时长
2.2 months
期刊介绍: Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry. In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信